Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at everolimus, exemestane and capecitabine for advanced breast cancer (BOLERO 6)

Overview

Cancer types:

Breast cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at 3 treatments for breast cancer that had spread outside the breast. This is locally advanced or metastatic breast cancer.

It was for women after the . And whose breast cancer:

  • had receptors for the hormone oestrogen ()

  • didn’t have receptors for a protein called HER2 ()

This trial was open for women to join between 2013 and 2014, and published in 2018.

Recruitment start: 14 August 2013

Recruitment end: 22 October 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Stephen Chan

Supported by

Novartis

Last reviewed: 16 April 2020

CRUK internal database number: 12152

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.